tradingkey.logo

Qiagen & Incyte Announce Precision Medicine Collaboration To Develop Companion Diagnostics For Patients With Mutant Calr-Expressing Myeloproliferative Neoplasms

ReutersJun 15, 2025 8:08 AM

- Incyte Corp INCY.O:

  • QIAGEN AND INCYTE ANNOUNCE PRECISION MEDICINE COLLABORATION TO DEVELOP COMPANION DIAGNOSTICS FOR PATIENTS WITH MUTANT CALR-EXPRESSING MYELOPROLIFERATIVE NEOPLASMS (MPNS)

  • INCYTE CORP - QIAGEN TO CREATE MULTIMODAL PANEL USING NGS TECHNOLOGY

  • INCYTE CORP - DIAGNOSTIC TO IDENTIFY KEY MUTATIONS IN MPN PATIENTS

  • INCYTE CORP - QIAGEN TO DEVELOP MULTIMODAL PANEL UNDER AGREEMENT WITH INCYTE

  • INCYTE CORP - QIAGEN TO SUPPORT REGULATORY SUBMISSIONS IN US, EU, ASIA-PACIFIC

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI